Oruka Therapeutics, Inc. (ORKA) Net income

annual net income:

-$83.72M-$78.39M(-1468.16%)
December 31, 2024

Summary

  • As of today (August 20, 2025), ORKA annual net profit is -$83.72 million, with the most recent change of -$78.39 million (-1468.16%) on December 31, 2024.
  • During the last 3 years, ORKA annual net income has fallen by -$64.40 million (-333.31%).
  • ORKA annual net income is now -1838.06% below its all-time high of -$4.32 million, reached on December 1, 2012.

Performance

ORKA Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherORKAincome statement metrics

quarterly net income:

-$24.57M-$3.58M(-17.02%)
June 30, 2025

Summary

  • As of today (August 20, 2025), ORKA quarterly net profit is -$24.57 million, with the most recent change of -$3.58 million (-17.02%) on June 30, 2025.
  • Over the past year, ORKA quarterly net income has dropped by -$2.33 million (-10.48%).
  • ORKA quarterly net income is now -184.62% below its all-time high of $29.04 million, reached on June 1, 2007.

Performance

ORKA quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherORKAincome statement metrics

TTM net income:

-$99.98M-$2.33M(-2.39%)
June 30, 2025

Summary

  • As of today (August 20, 2025), ORKA TTM net profit is -$99.98 million, with the most recent change of -$2.33 million (-2.39%) on June 30, 2025.
  • Over the past year, ORKA TTM net income has dropped by -$68.14 million (-214.07%).
  • ORKA TTM net income is now -11974.52% below its all-time high of -$828.00 thousand, reached on March 1, 2008.

Performance

ORKA TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherORKAincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

ORKA Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-1468.2%-10.5%-214.1%
3 y3 years-333.3%-680.9%-494.9%
5 y5 years-1427.3%-1787.4%-1897.9%

ORKA Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1468.2%at low-2156.6%+14.2%-1772.6%at low
5 y5-year-1468.2%at low-2156.6%+14.2%-1897.9%at low
alltimeall time-1838.1%+36.9%-184.6%+63.6%<-9999.0%+24.7%

ORKA Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
-$24.57M(+17.0%)
-$99.98M(+2.4%)
Mar 2025
-
-$21.00M(-18.5%)
-$97.65M(+16.6%)
Dec 2024
-$83.72M(+1468.2%)
-$25.78M(-9.9%)
-$83.72M(+41.8%)
Sep 2024
-
-$28.62M(+28.7%)
-$59.03M(+85.4%)
Jun 2024
-
-$22.24M(+214.3%)
-$31.83M(+187.6%)
Mar 2024
-
-$7.08M(+549.9%)
-$11.07M(+107.3%)
Dec 2023
-$5.34M(-46.2%)
-
-
Dec 2023
-
-$1.09M(-23.5%)
-$5.34M(-1.6%)
Sep 2023
-
-$1.42M(-3.8%)
-$5.42M(-14.4%)
Jun 2023
-
-$1.48M(+10.0%)
-$6.33M(-20.8%)
Mar 2023
-
-$1.35M(+14.7%)
-$8.00M(-19.4%)
Dec 2022
-$9.93M(-48.6%)
-
-
Dec 2022
-
-$1.17M(-49.7%)
-$9.93M(-31.2%)
Sep 2022
-
-$2.33M(-25.9%)
-$14.43M(-14.2%)
Jun 2022
-
-$3.15M(-3.8%)
-$16.81M(-9.1%)
Mar 2022
-
-$3.27M(-42.4%)
-$18.49M(-4.3%)
Dec 2021
-$19.32M(+98.4%)
-
-
Dec 2021
-
-$5.68M(+20.5%)
-$19.32M(+2.9%)
Sep 2021
-
-$4.71M(-2.5%)
-$18.77M(+17.0%)
Jun 2021
-
-$4.83M(+17.9%)
-$16.05M(+28.2%)
Mar 2021
-
-$4.10M(-20.0%)
-$12.52M(+28.5%)
Dec 2020
-$9.74M(+77.6%)
-$5.13M(+157.4%)
-$9.74M(+66.8%)
Sep 2020
-
-$1.99M(+52.9%)
-$5.84M(+16.7%)
Jun 2020
-
-$1.30M(-1.4%)
-$5.00M(-2.6%)
Mar 2020
-
-$1.32M(+7.7%)
-$5.14M(-6.3%)
Dec 2019
-$5.48M(-30.9%)
-$1.23M(+6.1%)
-$5.48M(-4.6%)
Sep 2019
-
-$1.16M(-19.5%)
-$5.75M(-7.1%)
Jun 2019
-
-$1.44M(-13.7%)
-$6.18M(-9.9%)
Mar 2019
-
-$1.66M(+11.8%)
-$6.86M(-13.5%)
Dec 2018
-$7.93M(-57.1%)
-$1.49M(-6.5%)
-$7.93M(-25.4%)
Sep 2018
-
-$1.59M(-24.7%)
-$10.64M(-21.1%)
Jun 2018
-
-$2.12M(-22.6%)
-$13.48M(-20.2%)
Mar 2018
-
-$2.73M(-34.8%)
-$16.89M(-8.7%)
Dec 2017
-$18.49M(+12.4%)
-$4.20M(-5.3%)
-$18.49M(-0.3%)
Sep 2017
-
-$4.43M(-19.7%)
-$18.54M(-1.2%)
Jun 2017
-
-$5.52M(+27.3%)
-$18.76M(+9.5%)
Mar 2017
-
-$4.34M(+2.2%)
-$17.14M(+4.2%)
Dec 2016
-$16.44M(+43.7%)
-$4.24M(-8.9%)
-$16.44M(+7.0%)
Sep 2016
-
-$4.66M(+19.6%)
-$15.37M(+13.6%)
Jun 2016
-
-$3.89M(+6.8%)
-$13.52M(+9.5%)
Mar 2016
-
-$3.65M(+15.1%)
-$12.35M(+7.9%)
Dec 2015
-$11.45M(+18.1%)
-$3.17M(+12.6%)
-$11.45M(+5.1%)
Sep 2015
-
-$2.81M(+3.5%)
-$10.89M(+5.1%)
Jun 2015
-
-$2.72M(-0.9%)
-$10.36M(+3.1%)
Mar 2015
-
-$2.74M(+5.1%)
-$10.04M(+3.7%)
Dec 2014
-$9.69M(+39.6%)
-$2.61M(+14.3%)
-$9.69M(-3.3%)
Sep 2014
-
-$2.28M(-5.0%)
-$10.02M(+5.9%)
Jun 2014
-
-$2.40M(+0.7%)
-$9.46M(+14.6%)
Mar 2014
-
-$2.39M(-18.9%)
-$8.26M(+19.0%)
Dec 2013
-$6.94M
-$2.95M(+71.0%)
-$6.94M(+43.6%)
Sep 2013
-
-$1.72M(+43.7%)
-$4.83M(+19.7%)
Jun 2013
-
-$1.20M(+12.0%)
-$4.04M(+1.3%)
DateAnnualQuarterlyTTM
Mar 2013
-
-$1.07M(+27.5%)
-$3.98M(-7.8%)
Dec 2012
-$4.32M(-19.5%)
-$840.00K(-9.4%)
-$4.32M(-15.5%)
Sep 2012
-
-$927.00K(-19.1%)
-$5.11M(-14.9%)
Jun 2012
-
-$1.15M(-18.6%)
-$6.00M(+31.5%)
Mar 2012
-
-$1.41M(-13.7%)
-$4.57M(-14.9%)
Dec 2011
-$5.36M(-36.3%)
-$1.63M(-10.5%)
-$5.36M(+0.7%)
Sep 2011
-
-$1.82M(-719.7%)
-$5.33M(-5.1%)
Jun 2011
-
$294.00K(-113.3%)
-$5.61M(-31.4%)
Mar 2011
-
-$2.21M(+38.3%)
-$8.18M(-2.9%)
Dec 2010
-$8.42M(-7.9%)
-$1.59M(-24.3%)
-$8.42M(-35.3%)
Sep 2010
-
-$2.11M(-7.2%)
-$13.01M(-14.5%)
Jun 2010
-
-$2.27M(-7.3%)
-$15.21M(-29.3%)
Mar 2010
-
-$2.45M(-60.4%)
-$21.52M(+136.4%)
Dec 2009
-$9.14M(-53.0%)
-$6.19M(+43.6%)
-$9.11M(+12.5%)
Sep 2009
-
-$4.31M(-49.8%)
-$8.09M(-20.7%)
Jun 2009
-
-$8.58M(-186.1%)
-$10.20M(+82.5%)
Mar 2009
-
$9.97M(-292.6%)
-$5.59M(-71.2%)
Dec 2008
-$19.43M(+58.0%)
-$5.17M(-19.3%)
-$19.43M(-25.0%)
Sep 2008
-
-$6.42M(+61.8%)
-$25.89M(-23.5%)
Jun 2008
-
-$3.96M(+2.3%)
-$33.84M(+3986.4%)
Mar 2008
-
-$3.88M(-66.7%)
-$828.00K(-93.3%)
Dec 2007
-$12.30M(-90.7%)
-$11.64M(-19.0%)
-$12.30M(-82.0%)
Sep 2007
-
-$14.36M(-149.4%)
-$68.22M(-15.3%)
Jun 2007
-
$29.04M(-289.2%)
-$80.53M(-37.3%)
Mar 2007
-
-$15.35M(-77.3%)
-$128.47M(-3.2%)
Dec 2006
-$132.78M(+85.4%)
-$67.56M(+153.3%)
-$132.78M(+53.1%)
Sep 2006
-
-$26.67M(+41.1%)
-$86.70M(+10.5%)
Jun 2006
-
-$18.90M(-3.8%)
-$78.49M(+2.5%)
Mar 2006
-
-$19.65M(-8.5%)
-$76.60M(+7.0%)
Dec 2005
-$71.61M(+41.6%)
-$21.48M(+16.4%)
-$71.61M(+18.4%)
Sep 2005
-
-$18.46M(+8.5%)
-$60.46M(+15.6%)
Jun 2005
-
-$17.01M(+16.0%)
-$52.30M(+13.9%)
Mar 2005
-
-$14.66M(+41.9%)
-$45.93M(-6.2%)
Dec 2004
-$50.58M(+0.8%)
-$10.33M(+0.4%)
-$48.95M(+2.0%)
Sep 2004
-
-$10.29M(-3.3%)
-$48.01M(-1.3%)
Jun 2004
-
-$10.64M(-39.8%)
-$48.62M(-10.4%)
Mar 2004
-
-$17.68M(+88.3%)
-$54.28M(+8.2%)
Dec 2003
-$50.19M(+11.3%)
-$9.39M(-13.9%)
-$50.19M(-12.4%)
Sep 2003
-
-$10.91M(-33.1%)
-$57.31M(+19.8%)
Jun 2003
-
-$16.31M(+20.1%)
-$47.84M(+20.8%)
Mar 2003
-
-$13.58M(-17.7%)
-$39.60M(-12.2%)
Dec 2002
-$45.09M(+22.6%)
-$16.51M(+1043.4%)
-$45.09M(+12.1%)
Sep 2002
-
-$1.44M(-82.1%)
-$40.23M(-17.6%)
Jun 2002
-
-$8.07M(-57.7%)
-$48.80M(-0.7%)
Mar 2002
-
-$19.07M(+63.7%)
-$49.15M(+33.7%)
Dec 2001
-$36.77M(+65.2%)
-$11.65M(+16.4%)
-$36.76M(+15.6%)
Sep 2001
-
-$10.01M(+18.8%)
-$31.81M(+45.9%)
Jun 2001
-
-$8.43M(+26.2%)
-$21.80M(+63.0%)
Mar 2001
-
-$6.68M(-0.2%)
-$13.37M(+99.8%)
Dec 2000
-$22.25M(+20.0%)
-$6.70M(+31.8%)
-$6.70M(+31.8%)
Dec 1999
-$18.55M(+13.3%)
-$5.08M
-$5.08M
Dec 1998
-$16.37M
-
-

FAQ

  • What is Oruka Therapeutics, Inc. annual net profit?
  • What is the all time high annual net income for Oruka Therapeutics, Inc.?
  • What is Oruka Therapeutics, Inc. annual net income year-on-year change?
  • What is Oruka Therapeutics, Inc. quarterly net profit?
  • What is the all time high quarterly net income for Oruka Therapeutics, Inc.?
  • What is Oruka Therapeutics, Inc. quarterly net income year-on-year change?
  • What is Oruka Therapeutics, Inc. TTM net profit?
  • What is the all time high TTM net income for Oruka Therapeutics, Inc.?
  • What is Oruka Therapeutics, Inc. TTM net income year-on-year change?

What is Oruka Therapeutics, Inc. annual net profit?

The current annual net income of ORKA is -$83.72M

What is the all time high annual net income for Oruka Therapeutics, Inc.?

Oruka Therapeutics, Inc. all-time high annual net profit is -$4.32M

What is Oruka Therapeutics, Inc. annual net income year-on-year change?

Over the past year, ORKA annual net profit has changed by -$78.39M (-1468.16%)

What is Oruka Therapeutics, Inc. quarterly net profit?

The current quarterly net income of ORKA is -$24.57M

What is the all time high quarterly net income for Oruka Therapeutics, Inc.?

Oruka Therapeutics, Inc. all-time high quarterly net profit is $29.04M

What is Oruka Therapeutics, Inc. quarterly net income year-on-year change?

Over the past year, ORKA quarterly net profit has changed by -$2.33M (-10.48%)

What is Oruka Therapeutics, Inc. TTM net profit?

The current TTM net income of ORKA is -$99.98M

What is the all time high TTM net income for Oruka Therapeutics, Inc.?

Oruka Therapeutics, Inc. all-time high TTM net profit is -$828.00K

What is Oruka Therapeutics, Inc. TTM net income year-on-year change?

Over the past year, ORKA TTM net profit has changed by -$68.14M (-214.07%)
On this page